Dogwood Therapeutics, Inc. (DWTX) vs ImageneBio Inc (IMA)
A side-by-side comparison of Dogwood Therapeutics, Inc. and ImageneBio Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DWTX
Dogwood Therapeutics, Inc.
$1.56HealthcareDelayed quote: Oct 6, 2026, 12:09 PM EDT
IMA
ImageneBio Inc
$4.70HealthcareDelayed quote: Oct 6, 2026, 12:01 PM EDT
Total return — DWTX vs IMA
growth of $100 · dividends reinvested · last 6yDWTX -98.8% (-52.4%/yr)IMA -98.8% (-52.0%/yr)IMA compounded faster over this window
DWTX IMA
DWTX vs IMA: by the numbers
- •IMA is the larger company ($53M vs $52M market cap).
- •Both run net losses; DWTX's is the smaller (0.00% vs -5668.62% net margin).
Metrics side by side
Valuation
| Metric | DWTX | IMA |
|---|---|---|
| P/B ratio | 0.77 | 0.37 |
Profitability
| Metric | DWTX | IMA |
|---|---|---|
| Gross margin | 0.00% | -29.12% |
| Operating margin | 0.00% | -6056.37% |
| Net margin | 0.00% | -5668.62% |
| ROE | -52.72% | -36.94% |
| ROIC | -38.04% | -40.53% |
Growth (annualized)
| Metric | DWTX | IMA |
|---|---|---|
| Total return CAGR (5Y) | -58.44% | -50.73% |
Frequently asked
- How have DWTX and IMA total returns compared?
- Over the past 5 years, DWTX delivered -58.44% and IMA delivered -50.73% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.